Genetics & Genomics

Cowden Syndrome: What Oncology Nurses Need to Know About Increased Risk of Developing Certain Cancers

Laura C. Curr Beamer

Cowden syndrome, genetic cancer syndromes, breast cancer, risk management, cancer prevention
ONF 2014, 41(5), 555-557. DOI: 10.1188/14.ONF.555-557

Cowden syndrome (CS) is a genetic disorder characterized by multiple benign tissue growths (i.e., hamartomas) and an increased risk of developing specific cancers, such as breast, thyroid, kidney, endometrial, or colorectal cancer (Genetics Home Reference, 2012). This genetic syndrome was named after a person diagnosed with the disorder (Lloyd & Dennis, 1963). CS is part of a larger syndrome called PTEN hamartomatous syndrome, which also includes Bannayan-Riley-Ruvalcaba syndrome, PTEN-related Proteus syndrome, and Proteus-like syndrome (Eng, 2014).

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.